| Page 2 | Kisaco Research
 
Edge AI Summit 2020
18-20 Nov 2020
VIRTUAL SUMMIT | PDT Timezone
A 2020 report by Frost & Sullivan stated that 90% of industrial enterprises will be utilising edge computing by 2022. The value of the data that can be gleaned from intelligence ‘in the field’ is clear, but the current limitations of low power, on-device compute, data management and processing across the edge computing landscape continue to pose multiple engineering challenges. We’re thrilled to announce the agenda for the 3rd annual Edge AI Summit, which was the first ever dedicated summit focused on deploying machine learning on devices, and on the network infrastructure that supports the intelligent IoT. This year is all about Edge AI case studies! From ultra-low-power microwatt applications at the ‘sensor edge’, to larger milliwatt examples at the ‘device edge’ up to the non-power constrained ‘server-network edge’; we’ll be gathering a global audience (virtually!) to explore the most innovative real-world use cases of hardware and software facilitating AI at the Edge with examples from Uber AI, Google, Bosch, Magic Leap, Rakuten and many more…
 
Animal Health, Nutrition and Technology Innovation Europe 2022
21-23 Feb 2022
London, UK
Now in its 7th year, Animal Health, Nutrition and Technology Innovation Europe is the sector’s premier Innovation Summit showcasing the most exciting investment opportunities globally and connecting businesses with investors and strategic corporate partners. Our mission is to engage all key participants in the value chain so we can address the full scope of how animal health impacts pet owners, veterinarians, and farmers today.Following overwhelming feedback from the market, we have significantly expanded our programme this year with new focused content on nutrition and technology, alongside our production and companion animal health content. We will be running 4 separate innovation showcases in production animal health, companion animal health, nutrition, and technology.Our new programme will address the full extent of this ever-evolving market. We are excited to provide an innovation platform that is bigger than ever and to continue to play a critical role in shaping the future of the animal health industry by presenting the most exciting innovations in prediction, prevention, and cure.Book now to come and see for yourself!
2024 Life Sciences Strategy Summit on IP and Exclusivity
 

Sarah Rowlands

Marketing Director

Sarah Rowlands

Marketing Director

Sarah Rowlands

Marketing Director
 

Alice Brown

Senior Marketing Manager

Alice Brown

Senior Marketing Manager

Alice Brown

Senior Marketing Manager
 

Blerta Asanraka

Delegate Audience Manager
Book a meeting with Blerta

Blerta Asanraka

Delegate Audience Manager

Blerta Asanraka

Delegate Audience Manager
 

Ellie Bilko

Senior Commercial Partnership Manager
Book a meeting with Ellie

Ellie Bilko

Senior Commercial Partnership Manager

Ellie Bilko

Senior Commercial Partnership Manager
 

Chris Goy

Portfolio Director, Life Science & Healthcare

Chris Goy

Portfolio Director, Life Science & Healthcare

Chris Goy

Portfolio Director, Life Science & Healthcare

Given the complexity and cost of the commercialisation journey, strategic alliances and partnerships become a key decision for all founders. This panel will discuss the who, the why, and perhaps most crucially the decision around when to partner.

  • Improving capital efficiency within the animal health market
  • Factors to consider when evaluating and planning route to market
  • How strategic partners will leverage data and AI to help guide start-ups and speed to commercialisation
  • Drivers of successful partnerships and the realisation of value
Moderator

Author:

Rimma Driscoll

Executive Vice President, Global Strategy, Portfolio Marketing and Business Development, Global BioDevices and Platinum Performance
Zoetis

Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.

Rimma Driscoll

Executive Vice President, Global Strategy, Portfolio Marketing and Business Development, Global BioDevices and Platinum Performance
Zoetis

Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.

Panellists

Author:

Megan Grether

Head of Global Business Development and Licensing Animal Health
Boehringer Ingelheim

Megan Grether

Head of Global Business Development and Licensing Animal Health
Boehringer Ingelheim

Author:

Jim McIntyre

Head of Global Business Development
Merck Animal Health

Jim McIntyre

Head of Global Business Development
Merck Animal Health

Author:

Justine Conway

Vice President of Business Development & External Innovation
Elanco

Justine Conway

Vice President of Business Development & External Innovation
Elanco